Clinical Trials Insight: 700028680
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2010
At a glance
- Drugs Herpes simplex vaccine; ImmunoVEX HSV2
- Indications Herpes genitalis; Herpes simplex virus type 2 infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors BioVex
- 05 Mar 2010 Status changed from recruiting to active, no longer recruiting, as reported by BioVex.
- 05 Mar 2010 Results data are expected in late 2010, as reported by BioVex.
- 20 Aug 2008 Status change from planning to initiated, according to a BioVex media release.